S&P 500 (NYSE:SPY) component Sigma-Aldrich Corp (NASDAQ:SIAL) will unveil its latest earnings on Tuesday, July 26, 2011. Sigma-Aldrich Corporation is a life science and high technology company that develops, manufactures, purchases and distributes a range of high quality chemicals, biochemicals and equipment.
Sigma-Aldrich Corp Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 92 cents per share, a rise of 13.6% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 88 cents. For the year, analysts are projecting net income of $3.71 per share, a rise of 12.1% from last year.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 5 cents, reporting profit of 94 cents per share against a mean estimate of net income of 89 cents per share.
Wall St. Revenue Expectations: On average, analysts predict $620.6 million in revenue this quarter, a rise of 12% from the year ago quarter. Analysts are forecasting total revenue of $2.51 billion for the year, a rise of 10.1% from last year’s revenue of $2.28 billion.
Analyst Ratings: Analysts are bullish on this stock with six analysts rating it as a buy, none rating it as a sell and five rating it as a hold.
The company has now seen net income rise in three straight quarters. In the first quarter, net income rose 19% while it rose 1.5% in the fourth quarter of the last fiscal year and 8% in the third quarter of the last fiscal year.
Revenue has risen the past four quarters. Revenue increased 10.5% to $632 million in first quarter. The figure rose 1.7% in the fourth quarter of the last fiscal year from the year earlier, climbed 5.5% in the third quarter of the last fiscal year from the year-ago quarter and 6.1% in the second quarter of the last fiscal year.
Competitors to Watch: Techne Corporation (NASDAQ:TECH), Life Technologies Corp. (NASDAQ:LIFE), Qiagen NV (NASDAQ:QGEN), Thermo Fisher Scientific Inc. (NYSE:TMO), Affymetrix, Inc. (NASDAQ:AFFX), Hawkins, Inc. (NASDAQ:HWKN), Enzo Biochem, Inc. (NYSE:ENZ), Aceto Corporation (NASDAQ:ACET), Strategic Diagnostics Inc. (NASDAQ:SDIX), and PerkinElmer, Inc. (NYSE:PKI).
Stock Price Performance: During April 25, 2011 to July 20, 2011, the stock price had risen $5.69 (8.5%) from $67.10 to $72.79. The stock price saw one of its best stretches over the last year between April 18, 2011 and April 27, 2011 when shares rose for seven-straight days, rising 9% (+$5.78) over that span. It saw one of its worst periods between April 5, 2011 and April 13, 2011 when shares fell for seven-straight days, falling 3.2% (-$2.13) over that span. Shares are up $6.59 (+10%) year to date.
(Source: Xignite Financials)
Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!